➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:


Last Updated: June 5, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for GKT137831

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug GKT137831?

GKT137831 is an investigational drug.

There have been 5 clinical trials for GKT137831. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2013.

The most common disease conditions in clinical trials are Liver Cirrhosis, Biliary, Cholangitis, and Diabetic Nephropathies. The leading clinical trial sponsors are Genkyotex SA, University of Alabama at Birmingham, and York Bioanalytical Solution.

There are six US patents protecting this investigational drug and fifty-seven international patents.

Recent Clinical Trials for GKT137831
Study to Evaluate the Pharmacokinetics and Drug-Drug Interactions of Setanaxib in Healthy Adult Male and Female SubjectsGenkyotex SAPhase 1
GKT137831 in IPF Patients With Idiopathic Pulmonary FibrosisUniversity of Alabama at BirminghamPhase 2
Bioequivalence StudyEurofins OptimedPhase 1

See all GKT137831 clinical trials

Clinical Trial Summary for GKT137831

Top disease conditions for GKT137831
Top clinical trial sponsors for GKT137831

See all GKT137831 clinical trials

US Patents for GKT137831

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
GKT137831   Start Trial Pyrazolo pyridine derivatives as NADPH oxidase inhibitors GENKYOTEX SA (Plan-les-Ouates, CH)   Start Trial
GKT137831   Start Trial Methods of preserving and protecting pancreatic beta cells and treating or preventing diabetes by inhibiting NOX-1 Eastern Virginia Medical School (Norfolk, VA)   Start Trial
GKT137831   Start Trial Orvepitant for chronic cough therapy NeRRe Therapeutics Limited (Herts, GB)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.